Claris Advisors’s Dentsply Sirona XRAY Stock Holding History

Claris Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12	Closed	-$325	–	1193
2024 Q3	$325	Buy	+12	New	+$306	﹤0.01%	804

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Claris Advisors's XRAY Position: Q4 2024 in Review

Claris Advisors sold out of Dentsply Sirona (XRAY) in Q4 2024, closing a stake of 12 shares — an estimated $325 sold.

Claris Advisors first reported a position in XRAY in Q3 2024 and held it in 1 quarter. The position peaked at $325 in Q3 2024. 359 funds tracked by Wall St. Rank hold XRAY as of Q4 2024.

Claris Advisors reported no remaining Dentsply Sirona position as of Q4 2024 after selling out during the quarter.
Claris Advisors sold 12 Dentsply Sirona shares in Q4 2024, an estimated $325.
Claris Advisors first reported a position in Dentsply Sirona in Q3 2024 and held it in 1 quarter.
Claris Advisors's Dentsply Sirona position peaked at $325 in Q3 2024.
359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.